nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Vitamin D (calciferol) metabolism—CUBN—melanoma	0.101	0.22	CbGpPWpGaD
Gentamicin—LRP2—neck—melanoma	0.0352	0.344	CbGeAlD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—CUBN—melanoma	0.0292	0.0636	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—AKR1B10—melanoma	0.0286	0.0623	CbGpPWpGaD
Gentamicin—LRP2—eye—melanoma	0.0262	0.256	CbGeAlD
Gentamicin—LRP2—retina—melanoma	0.026	0.254	CbGeAlD
Gentamicin—LRP2—Diseases associated with visual transduction—MYO7A—melanoma	0.0248	0.0539	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—CUBN—melanoma	0.0206	0.0449	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—CYP17A1—melanoma	0.0176	0.0383	CbGpPWpGaD
Gentamicin—LRP2—head—melanoma	0.0149	0.145	CbGeAlD
Gentamicin—LRP2—Diseases associated with visual transduction—AKR1B10—melanoma	0.0146	0.0318	CbGpPWpGaD
Gentamicin—Nephrotoxicity—Carmustine—melanoma	0.0144	0.0329	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Bleomycin—melanoma	0.0119	0.0272	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Carmustine—melanoma	0.0104	0.0238	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Temozolomide—melanoma	0.0101	0.023	CcSEcCtD
Gentamicin—Nephropathy toxic—Bleomycin—melanoma	0.00914	0.0209	CcSEcCtD
Gentamicin—Hypomagnesaemia—Bleomycin—melanoma	0.00826	0.0189	CcSEcCtD
Gentamicin—Nephropathy toxic—Carmustine—melanoma	0.00798	0.0182	CcSEcCtD
Gentamicin—Neurotoxicity—Docetaxel—melanoma	0.00759	0.0173	CcSEcCtD
Gentamicin—Encephalopathy—Carmustine—melanoma	0.00714	0.0163	CcSEcCtD
Gentamicin—Hepatomegaly—Dactinomycin—melanoma	0.00692	0.0158	CcSEcCtD
Gentamicin—Pulmonary fibrosis—Docetaxel—melanoma	0.00669	0.0153	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—ICAM1—melanoma	0.00646	0.0141	CbGpPWpGaD
Gentamicin—Extravasation—Bleomycin—melanoma	0.00602	0.0137	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00592	0.0129	CbGpPWpGaD
Gentamicin—Injection site pain—Carmustine—melanoma	0.00561	0.0128	CcSEcCtD
Gentamicin—Extravasation—Dactinomycin—melanoma	0.00561	0.0128	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—melanoma	0.00548	0.0119	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ALB—melanoma	0.00539	0.0117	CbGpPWpGaD
Gentamicin—Eosinophilia—Vemurafenib—melanoma	0.00538	0.0123	CcSEcCtD
Gentamicin—Hypocalcaemia—Dactinomycin—melanoma	0.00535	0.0122	CcSEcCtD
Gentamicin—Extravasation—Carmustine—melanoma	0.00525	0.012	CcSEcCtD
Gentamicin—Weight decreased—Vemurafenib—melanoma	0.00492	0.0112	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IFNG—melanoma	0.00491	0.0107	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—PRKCA—melanoma	0.00482	0.0105	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Vemurafenib—melanoma	0.00475	0.0108	CcSEcCtD
Gentamicin—Hearing impaired—Temozolomide—melanoma	0.00465	0.0106	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—melanoma	0.00448	0.00975	CbGpPWpGaD
Gentamicin—Phlebitis—Bleomycin—melanoma	0.00442	0.0101	CcSEcCtD
Gentamicin—Phlebitis—Dactinomycin—melanoma	0.00412	0.00941	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—NFKB1—melanoma	0.00409	0.0089	CbGpPWpGaD
Gentamicin—Phlebitis—Carmustine—melanoma	0.00386	0.00881	CcSEcCtD
Gentamicin—Alopecia—Vemurafenib—melanoma	0.00384	0.00877	CcSEcCtD
Gentamicin—Erythema—Vemurafenib—melanoma	0.00379	0.00864	CcSEcCtD
Gentamicin—Lethargy—Dactinomycin—melanoma	0.00363	0.00827	CcSEcCtD
Gentamicin—Deafness—Temozolomide—melanoma	0.00359	0.0082	CcSEcCtD
Gentamicin—Vascular purpura—Temozolomide—melanoma	0.00359	0.0082	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.00359	0.00781	CbGpPWpGaD
Gentamicin—Extravasation—Docetaxel—melanoma	0.00337	0.0077	CcSEcCtD
Gentamicin—Purpura—Temozolomide—melanoma	0.00333	0.00761	CcSEcCtD
Gentamicin—Arthralgia—Vemurafenib—melanoma	0.00322	0.00736	CcSEcCtD
Gentamicin—Oliguria—Docetaxel—melanoma	0.0032	0.00729	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—melanoma	0.00318	0.00693	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYO7A—melanoma	0.00315	0.00685	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A11—melanoma	0.0031	0.00675	CbGpPWpGaD
Gentamicin—Hearing impaired—Docetaxel—melanoma	0.00309	0.00706	CcSEcCtD
Gentamicin—Anaphylactic shock—Vemurafenib—melanoma	0.00309	0.00705	CcSEcCtD
Gentamicin—Hypokalaemia—Carmustine—melanoma	0.00303	0.00691	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.00299	0.00651	CbGpPWpGaD
Gentamicin—Weight decreased—Bleomycin—melanoma	0.00298	0.0068	CcSEcCtD
Gentamicin—Muscular weakness—Carmustine—melanoma	0.00293	0.00669	CcSEcCtD
Gentamicin—Hypokalaemia—Temozolomide—melanoma	0.00293	0.00667	CcSEcCtD
Gentamicin—Hypotension—Vemurafenib—melanoma	0.00289	0.00659	CcSEcCtD
Gentamicin—Stomatitis—Bleomycin—melanoma	0.00286	0.00653	CcSEcCtD
Gentamicin—Muscular weakness—Temozolomide—melanoma	0.00283	0.00647	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00282	0.00642	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.0028	0.00609	CbGpPWpGaD
Gentamicin—Decreased appetite—Vemurafenib—melanoma	0.00269	0.00613	CcSEcCtD
Gentamicin—LRP2—Disease—HS3ST5—melanoma	0.00268	0.00583	CbGpPWpGaD
Gentamicin—Stomatitis—Dactinomycin—melanoma	0.00267	0.00609	CcSEcCtD
Gentamicin—LRP2—Metabolism—ACER3—melanoma	0.00264	0.00574	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Bleomycin—melanoma	0.00262	0.00598	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—melanoma	0.00257	0.00559	CbGpPWpGaD
Gentamicin—Agranulocytosis—Dactinomycin—melanoma	0.00256	0.00583	CcSEcCtD
Gentamicin—Weight decreased—Temozolomide—melanoma	0.00251	0.00573	CcSEcCtD
Gentamicin—Neuropathy peripheral—Carmustine—melanoma	0.00251	0.00573	CcSEcCtD
Gentamicin—Stomatitis—Carmustine—melanoma	0.0025	0.0057	CcSEcCtD
Gentamicin—Phlebitis—Docetaxel—melanoma	0.00248	0.00566	CcSEcCtD
Gentamicin—Body temperature increased—Vemurafenib—melanoma	0.00244	0.00557	CcSEcCtD
Gentamicin—Neuropathy peripheral—Temozolomide—melanoma	0.00243	0.00554	CcSEcCtD
Gentamicin—Stomatitis—Temozolomide—melanoma	0.00241	0.00551	CcSEcCtD
Gentamicin—LRP2—Metabolism—UGT2B10—melanoma	0.00241	0.00525	CbGpPWpGaD
Gentamicin—Deafness—Docetaxel—melanoma	0.00239	0.00545	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00238	0.00518	CbGpPWpGaD
Gentamicin—Alopecia—Bleomycin—melanoma	0.00233	0.00531	CcSEcCtD
Gentamicin—Erythema—Bleomycin—melanoma	0.00229	0.00523	CcSEcCtD
Gentamicin—Hallucination—Carmustine—melanoma	0.00229	0.00522	CcSEcCtD
Gentamicin—Hypoaesthesia—Carmustine—melanoma	0.00229	0.00522	CcSEcCtD
Gentamicin—Hypersensitivity—Vemurafenib—melanoma	0.00228	0.0052	CcSEcCtD
Gentamicin—Visual disturbance—Docetaxel—melanoma	0.00226	0.00515	CcSEcCtD
Gentamicin—LRP2—Metabolism—HS3ST5—melanoma	0.00224	0.00488	CbGpPWpGaD
Gentamicin—Visual impairment—Carmustine—melanoma	0.00222	0.00506	CcSEcCtD
Gentamicin—Hypoaesthesia—Temozolomide—melanoma	0.00221	0.00505	CcSEcCtD
Gentamicin—Hallucination—Temozolomide—melanoma	0.00221	0.00505	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MYO7A—melanoma	0.0022	0.0048	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DRAP1—melanoma	0.0022	0.0048	CbGpPWpGaD
Gentamicin—Pruritus—Vemurafenib—melanoma	0.00219	0.00499	CcSEcCtD
Gentamicin—Lethargy—Docetaxel—melanoma	0.00218	0.00498	CcSEcCtD
Gentamicin—Alopecia—Dactinomycin—melanoma	0.00217	0.00496	CcSEcCtD
Gentamicin—Visual impairment—Temozolomide—melanoma	0.00214	0.00489	CcSEcCtD
Gentamicin—Erythema—Dactinomycin—melanoma	0.00214	0.00488	CcSEcCtD
Gentamicin—Anaemia—Bleomycin—melanoma	0.00212	0.00484	CcSEcCtD
Gentamicin—Tinnitus—Temozolomide—melanoma	0.00207	0.00473	CcSEcCtD
Gentamicin—Leukopenia—Bleomycin—melanoma	0.00205	0.00469	CcSEcCtD
Gentamicin—Dizziness—Vemurafenib—melanoma	0.00204	0.00466	CcSEcCtD
Gentamicin—Alopecia—Carmustine—melanoma	0.00203	0.00464	CcSEcCtD
Gentamicin—Erythema—Carmustine—melanoma	0.002	0.00457	CcSEcCtD
Gentamicin—Anaemia—Dactinomycin—melanoma	0.00198	0.00451	CcSEcCtD
Gentamicin—Vomiting—Vemurafenib—melanoma	0.00197	0.00448	CcSEcCtD
Gentamicin—Alopecia—Temozolomide—melanoma	0.00196	0.00448	CcSEcCtD
Gentamicin—Rash—Vemurafenib—melanoma	0.00195	0.00445	CcSEcCtD
Gentamicin—Dermatitis—Vemurafenib—melanoma	0.00195	0.00444	CcSEcCtD
Gentamicin—Headache—Vemurafenib—melanoma	0.00194	0.00442	CcSEcCtD
Gentamicin—Erythema—Temozolomide—melanoma	0.00194	0.00442	CcSEcCtD
Gentamicin—Leukopenia—Dactinomycin—melanoma	0.00192	0.00437	CcSEcCtD
Gentamicin—LRP2—Disease—CUL3—melanoma	0.00191	0.00415	CbGpPWpGaD
Gentamicin—LRP2—Disease—TRRAP—melanoma	0.00191	0.00415	CbGpPWpGaD
Gentamicin—Confusional state—Bleomycin—melanoma	0.00189	0.00431	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TAS2R60—melanoma	0.00187	0.00408	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Bleomycin—melanoma	0.00187	0.00427	CcSEcCtD
Gentamicin—LRP2—Disease—AKR1B10—melanoma	0.00185	0.00404	CbGpPWpGaD
Gentamicin—Anaemia—Carmustine—melanoma	0.00185	0.00422	CcSEcCtD
Gentamicin—Nausea—Vemurafenib—melanoma	0.00184	0.00419	CcSEcCtD
Gentamicin—Thrombocytopenia—Bleomycin—melanoma	0.00183	0.00418	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.0018	0.00393	CbGpPWpGaD
Gentamicin—Leukopenia—Carmustine—melanoma	0.00179	0.00409	CcSEcCtD
Gentamicin—Anaemia—Temozolomide—melanoma	0.00179	0.00408	CcSEcCtD
Gentamicin—Hypotension—Bleomycin—melanoma	0.00175	0.00399	CcSEcCtD
Gentamicin—Vertigo—Temozolomide—melanoma	0.00174	0.00397	CcSEcCtD
Gentamicin—Convulsion—Carmustine—melanoma	0.00174	0.00396	CcSEcCtD
Gentamicin—Leukopenia—Temozolomide—melanoma	0.00173	0.00395	CcSEcCtD
Gentamicin—Hypertension—Carmustine—melanoma	0.00173	0.00395	CcSEcCtD
Gentamicin—Thrombocytopenia—Dactinomycin—melanoma	0.00171	0.0039	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00171	0.00389	CcSEcCtD
Gentamicin—LRP2—Metabolism—PLCB4—melanoma	0.0017	0.0037	CbGpPWpGaD
Gentamicin—Paraesthesia—Bleomycin—melanoma	0.00168	0.00384	CcSEcCtD
Gentamicin—Convulsion—Temozolomide—melanoma	0.00168	0.00383	CcSEcCtD
Gentamicin—Weight decreased—Docetaxel—melanoma	0.00167	0.00381	CcSEcCtD
Gentamicin—Hypertension—Temozolomide—melanoma	0.00167	0.00381	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—FASN—melanoma	0.00167	0.00363	CbGpPWpGaD
Gentamicin—LRP2—Disease—LUM—melanoma	0.00165	0.0036	CbGpPWpGaD
Gentamicin—Confusional state—Carmustine—melanoma	0.00165	0.00376	CcSEcCtD
Gentamicin—Arthralgia—Temozolomide—melanoma	0.00165	0.00376	CcSEcCtD
Gentamicin—Decreased appetite—Bleomycin—melanoma	0.00163	0.00371	CcSEcCtD
Gentamicin—LRP2—Disease—HPSE—melanoma	0.00162	0.00353	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Docetaxel—melanoma	0.00161	0.00368	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.00161	0.00351	CbGpPWpGaD
Gentamicin—Stomatitis—Docetaxel—melanoma	0.00161	0.00366	CcSEcCtD
Gentamicin—Thrombocytopenia—Carmustine—melanoma	0.0016	0.00365	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC6A11—melanoma	0.0016	0.00348	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIP4K2A—melanoma	0.0016	0.00348	CbGpPWpGaD
Gentamicin—Confusional state—Temozolomide—melanoma	0.00159	0.00363	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00159	0.00363	CcSEcCtD
Gentamicin—LRP2—Disease—CUBN—melanoma	0.00159	0.00346	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Temozolomide—melanoma	0.00158	0.0036	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB5—melanoma	0.00156	0.00339	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTAP—melanoma	0.00155	0.00338	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00155	0.00338	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Temozolomide—melanoma	0.00155	0.00353	CcSEcCtD
Gentamicin—Feeling abnormal—Bleomycin—melanoma	0.00154	0.00352	CcSEcCtD
Gentamicin—Agranulocytosis—Docetaxel—melanoma	0.00154	0.00351	CcSEcCtD
Gentamicin—LRP2—Disease—CSPG4—melanoma	0.00154	0.00335	CbGpPWpGaD
Gentamicin—Hypotension—Carmustine—melanoma	0.00153	0.00348	CcSEcCtD
Gentamicin—Decreased appetite—Dactinomycin—melanoma	0.00152	0.00346	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.00152	0.0033	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPS3—melanoma	0.00151	0.00329	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Carmustine—melanoma	0.00149	0.0034	CcSEcCtD
Gentamicin—LRP2—Disease—SKI—melanoma	0.00149	0.00324	CbGpPWpGaD
Gentamicin—Urticaria—Bleomycin—melanoma	0.00149	0.00339	CcSEcCtD
Gentamicin—Body temperature increased—Bleomycin—melanoma	0.00148	0.00338	CcSEcCtD
Gentamicin—Hypoaesthesia—Docetaxel—melanoma	0.00147	0.00336	CcSEcCtD
Gentamicin—Paraesthesia—Carmustine—melanoma	0.00147	0.00335	CcSEcCtD
Gentamicin—Feeling abnormal—Dactinomycin—melanoma	0.00144	0.00328	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00144	0.00328	CcSEcCtD
Gentamicin—Visual impairment—Docetaxel—melanoma	0.00142	0.00325	CcSEcCtD
Gentamicin—Decreased appetite—Carmustine—melanoma	0.00142	0.00324	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CXCL1—melanoma	0.00142	0.00309	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLCB4—melanoma	0.00142	0.00309	CbGpPWpGaD
Gentamicin—Paraesthesia—Temozolomide—melanoma	0.00142	0.00324	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00141	0.00307	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LUM—melanoma	0.00138	0.00301	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PHGDH—melanoma	0.00138	0.00301	CbGpPWpGaD
Gentamicin—Body temperature increased—Dactinomycin—melanoma	0.00138	0.00315	CcSEcCtD
Gentamicin—Hypersensitivity—Bleomycin—melanoma	0.00138	0.00315	CcSEcCtD
Gentamicin—Decreased appetite—Temozolomide—melanoma	0.00137	0.00313	CcSEcCtD
Gentamicin—LRP2—Metabolism—HPSE—melanoma	0.00136	0.00296	CbGpPWpGaD
Gentamicin—Feeling abnormal—Carmustine—melanoma	0.00135	0.00307	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TRRAP—melanoma	0.00134	0.00291	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CUL3—melanoma	0.00134	0.00291	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CUBN—melanoma	0.00133	0.0029	CbGpPWpGaD
Gentamicin—Pruritus—Bleomycin—melanoma	0.00132	0.00302	CcSEcCtD
Gentamicin—Alopecia—Docetaxel—melanoma	0.00131	0.00298	CcSEcCtD
Gentamicin—Feeling abnormal—Temozolomide—melanoma	0.0013	0.00297	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AKR1B10—melanoma	0.0013	0.00283	CbGpPWpGaD
Gentamicin—Body temperature increased—Carmustine—melanoma	0.00129	0.00295	CcSEcCtD
Gentamicin—Erythema—Docetaxel—melanoma	0.00129	0.00294	CcSEcCtD
Gentamicin—LRP2—Metabolism—SDHD—melanoma	0.00129	0.0028	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—BSG—melanoma	0.00129	0.0028	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CSPG4—melanoma	0.00129	0.0028	CbGpPWpGaD
Gentamicin—Hypersensitivity—Dactinomycin—melanoma	0.00129	0.00294	CcSEcCtD
Gentamicin—Urticaria—Temozolomide—melanoma	0.00125	0.00286	CcSEcCtD
Gentamicin—Body temperature increased—Temozolomide—melanoma	0.00125	0.00285	CcSEcCtD
Gentamicin—LRP2—Metabolism—GPAM—melanoma	0.00125	0.00271	CbGpPWpGaD
Gentamicin—LRP2—Disease—HDAC6—melanoma	0.00123	0.00267	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—F2RL1—melanoma	0.00121	0.00263	CbGpPWpGaD
Gentamicin—Hypersensitivity—Carmustine—melanoma	0.0012	0.00275	CcSEcCtD
Gentamicin—Vomiting—Bleomycin—melanoma	0.00119	0.00272	CcSEcCtD
Gentamicin—Anaemia—Docetaxel—melanoma	0.00119	0.00271	CcSEcCtD
Gentamicin—Rash—Bleomycin—melanoma	0.00118	0.00269	CcSEcCtD
Gentamicin—Dermatitis—Bleomycin—melanoma	0.00118	0.00269	CcSEcCtD
Gentamicin—LRP2—Disease—NPPA—melanoma	0.00116	0.00254	CbGpPWpGaD
Gentamicin—Hypersensitivity—Temozolomide—melanoma	0.00116	0.00266	CcSEcCtD
Gentamicin—Leukopenia—Docetaxel—melanoma	0.00115	0.00263	CcSEcCtD
Gentamicin—LRP2—Disease—VCAN—melanoma	0.00114	0.00247	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRM3—melanoma	0.00114	0.00247	CbGpPWpGaD
Gentamicin—LRP2—Disease—WNT5A—melanoma	0.00113	0.00246	CbGpPWpGaD
Gentamicin—Pruritus—Temozolomide—melanoma	0.00112	0.00255	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—melanoma	0.00112	0.00254	CcSEcCtD
Gentamicin—Nausea—Bleomycin—melanoma	0.00111	0.00254	CcSEcCtD
Gentamicin—Hypertension—Docetaxel—melanoma	0.00111	0.00254	CcSEcCtD
Gentamicin—Vomiting—Dactinomycin—melanoma	0.00111	0.00253	CcSEcCtD
Gentamicin—Rash—Dactinomycin—melanoma	0.0011	0.00251	CcSEcCtD
Gentamicin—Arthralgia—Docetaxel—melanoma	0.0011	0.0025	CcSEcCtD
Gentamicin—Dizziness—Carmustine—melanoma	0.00108	0.00247	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ARL2—melanoma	0.00108	0.00235	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KISS1—melanoma	0.00108	0.00234	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLA2G6—melanoma	0.00106	0.00231	CbGpPWpGaD
Gentamicin—Confusional state—Docetaxel—melanoma	0.00106	0.00242	CcSEcCtD
Gentamicin—Anaphylactic shock—Docetaxel—melanoma	0.00105	0.0024	CcSEcCtD
Gentamicin—Dizziness—Temozolomide—melanoma	0.00104	0.00238	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SKI—melanoma	0.00104	0.00227	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCR1—melanoma	0.00104	0.00227	CbGpPWpGaD
Gentamicin—Vomiting—Carmustine—melanoma	0.00104	0.00237	CcSEcCtD
Gentamicin—Nausea—Dactinomycin—melanoma	0.00104	0.00237	CcSEcCtD
Gentamicin—Rash—Carmustine—melanoma	0.00103	0.00235	CcSEcCtD
Gentamicin—Dermatitis—Carmustine—melanoma	0.00103	0.00235	CcSEcCtD
Gentamicin—Thrombocytopenia—Docetaxel—melanoma	0.00103	0.00235	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MC1R—melanoma	0.00103	0.00224	CbGpPWpGaD
Gentamicin—Headache—Carmustine—melanoma	0.00102	0.00234	CcSEcCtD
Gentamicin—Vomiting—Temozolomide—melanoma	0.001	0.00229	CcSEcCtD
Gentamicin—Rash—Temozolomide—melanoma	0.000996	0.00227	CcSEcCtD
Gentamicin—Dermatitis—Temozolomide—melanoma	0.000995	0.00227	CcSEcCtD
Gentamicin—Headache—Temozolomide—melanoma	0.00099	0.00226	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCR7—melanoma	0.000984	0.00214	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRM1—melanoma	0.000984	0.00214	CbGpPWpGaD
Gentamicin—Hypotension—Docetaxel—melanoma	0.000982	0.00224	CcSEcCtD
Gentamicin—Nausea—Carmustine—melanoma	0.000971	0.00222	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SUFU—melanoma	0.000959	0.00209	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Docetaxel—melanoma	0.000957	0.00218	CcSEcCtD
Gentamicin—LRP2—Metabolism—VCAN—melanoma	0.000952	0.00207	CbGpPWpGaD
Gentamicin—Paraesthesia—Docetaxel—melanoma	0.000943	0.00215	CcSEcCtD
Gentamicin—Nausea—Temozolomide—melanoma	0.000938	0.00214	CcSEcCtD
Gentamicin—Decreased appetite—Docetaxel—melanoma	0.000913	0.00208	CcSEcCtD
Gentamicin—LRP2—Disease—GAB2—melanoma	0.000906	0.00197	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000901	0.00196	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BCL2L11—melanoma	0.000895	0.00195	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RHOB—melanoma	0.000895	0.00195	CbGpPWpGaD
Gentamicin—LRP2—Disease—FASN—melanoma	0.000886	0.00193	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.00087	0.00189	CbGpPWpGaD
Gentamicin—Feeling abnormal—Docetaxel—melanoma	0.000866	0.00197	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HDAC6—melanoma	0.00086	0.00187	CbGpPWpGaD
Gentamicin—LRP2—Disease—CXCR4—melanoma	0.000852	0.00185	CbGpPWpGaD
Gentamicin—LRP2—Disease—FOXO4—melanoma	0.000852	0.00185	CbGpPWpGaD
Gentamicin—LRP2—Disease—HDAC2—melanoma	0.000852	0.00185	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD44—melanoma	0.000842	0.00183	CbGpPWpGaD
Gentamicin—Body temperature increased—Docetaxel—melanoma	0.00083	0.00189	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000819	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCR2—melanoma	0.000816	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP17A1—melanoma	0.000803	0.00175	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAC2—melanoma	0.000802	0.00175	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000792	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—WNT5A—melanoma	0.00079	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFC—melanoma	0.00079	0.00172	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000788	0.00172	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000782	0.0017	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT3—melanoma	0.000777	0.00169	CbGpPWpGaD
Gentamicin—Hypersensitivity—Docetaxel—melanoma	0.000774	0.00177	CcSEcCtD
Gentamicin—LRP2—Metabolism—GNA11—melanoma	0.000759	0.00165	CbGpPWpGaD
Gentamicin—Pruritus—Docetaxel—melanoma	0.000743	0.0017	CcSEcCtD
Gentamicin—LRP2—Metabolism—FASN—melanoma	0.000742	0.00162	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC5A5—melanoma	0.00073	0.00159	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000716	0.00156	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GNAQ—melanoma	0.000705	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CD44—melanoma	0.000705	0.00154	CbGpPWpGaD
Gentamicin—Dizziness—Docetaxel—melanoma	0.000695	0.00158	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—F2R—melanoma	0.000693	0.00151	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.000691	0.0015	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB4—melanoma	0.000686	0.00149	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000684	0.00149	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN2B—melanoma	0.00068	0.00148	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP1B1—melanoma	0.000676	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EDNRB—melanoma	0.000672	0.00146	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—melanoma	0.000668	0.00152	CcSEcCtD
Gentamicin—Rash—Docetaxel—melanoma	0.000662	0.00151	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—melanoma	0.000662	0.00151	CcSEcCtD
Gentamicin—Headache—Docetaxel—melanoma	0.000658	0.0015	CcSEcCtD
Gentamicin—LRP2—Disease—CD86—melanoma	0.000658	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTK2B—melanoma	0.000652	0.00142	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000644	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF1—melanoma	0.000638	0.00139	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GAB2—melanoma	0.000634	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GNA11—melanoma	0.000634	0.00138	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FLT1—melanoma	0.000631	0.00137	CbGpPWpGaD
Gentamicin—Nausea—Docetaxel—melanoma	0.000624	0.00142	CcSEcCtD
Gentamicin—LRP2—Disease—PDGFRA—melanoma	0.000618	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Disease—PRKCA—melanoma	0.000612	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERCC2—melanoma	0.000607	0.00132	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAP2K2—melanoma	0.000598	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000597	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HDAC2—melanoma	0.000596	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCR4—melanoma	0.000596	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FOXO4—melanoma	0.000596	0.0013	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GNAQ—melanoma	0.00059	0.00128	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—melanoma	0.000569	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Disease—HLA-A—melanoma	0.000569	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Disease—RAC1—melanoma	0.000567	0.00123	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCB1—melanoma	0.000557	0.00121	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SYK—melanoma	0.000554	0.00121	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT3—melanoma	0.000544	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ITGAV—melanoma	0.000544	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NGFR—melanoma	0.000544	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—melanoma	0.000544	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PRKCA—melanoma	0.000512	0.00112	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ERCC2—melanoma	0.000508	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SOCS1—melanoma	0.000504	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—S100B—melanoma	0.000503	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS2—melanoma	0.000495	0.00108	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOTCH1—melanoma	0.00049	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB4—melanoma	0.000481	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD80—melanoma	0.00048	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Disease—APC—melanoma	0.000479	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Disease—KIT—melanoma	0.000479	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN2B—melanoma	0.000476	0.00104	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGF—melanoma	0.000474	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CD86—melanoma	0.000461	0.001	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EDN1—melanoma	0.000457	0.000995	CbGpPWpGaD
Gentamicin—LRP2—Disease—BRAF—melanoma	0.00045	0.000981	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF1—melanoma	0.000447	0.000973	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CSF2—melanoma	0.000447	0.000973	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—E2F1—melanoma	0.000437	0.000952	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDGFRA—melanoma	0.000433	0.000942	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKCA—melanoma	0.000428	0.000933	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ITGB3—melanoma	0.000428	0.000933	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAP2K1—melanoma	0.000424	0.000923	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CD—melanoma	0.000421	0.000917	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000421	0.000916	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPP1—melanoma	0.00042	0.000915	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAP2K2—melanoma	0.000419	0.000912	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGF2—melanoma	0.000403	0.000878	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—melanoma	0.000401	0.000874	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—melanoma	0.000398	0.000867	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAC1—melanoma	0.000397	0.000865	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARG—melanoma	0.000387	0.000843	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIF1A—melanoma	0.000381	0.000829	CbGpPWpGaD
Gentamicin—LRP2—Disease—MDM2—melanoma	0.000377	0.000822	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—melanoma	0.000372	0.00081	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CB—melanoma	0.000367	0.000799	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD4—melanoma	0.000367	0.000798	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KDR—melanoma	0.000364	0.000793	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—melanoma	0.000364	0.000792	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CD—melanoma	0.000353	0.000768	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FN1—melanoma	0.000351	0.000763	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALB—melanoma	0.000348	0.000758	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1B—melanoma	0.000345	0.00075	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH1—melanoma	0.000343	0.000747	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CD80—melanoma	0.000336	0.000732	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—melanoma	0.000336	0.000731	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KIT—melanoma	0.000336	0.000731	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—melanoma	0.000336	0.000731	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGF—melanoma	0.000332	0.000722	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000327	0.000713	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—melanoma	0.000326	0.000709	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—melanoma	0.000318	0.000692	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—melanoma	0.000317	0.000691	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BRAF—melanoma	0.000315	0.000687	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CB—melanoma	0.000308	0.000669	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—melanoma	0.000307	0.000669	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—melanoma	0.000307	0.000669	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—melanoma	0.000305	0.000663	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAP2K1—melanoma	0.000297	0.000647	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—melanoma	0.000295	0.000642	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—melanoma	0.000284	0.000618	CbGpPWpGaD
Gentamicin—LRP2—Disease—NRAS—melanoma	0.000283	0.000616	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF2—melanoma	0.000282	0.000615	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK3—melanoma	0.000271	0.00059	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTEN—melanoma	0.000266	0.000579	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MDM2—melanoma	0.000264	0.000575	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—melanoma	0.000264	0.000574	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—melanoma	0.000261	0.000567	CbGpPWpGaD
Gentamicin—LRP2—Disease—MAPK1—melanoma	0.000258	0.000562	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—melanoma	0.000258	0.000561	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—melanoma	0.000257	0.00056	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB1—melanoma	0.00025	0.000543	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—melanoma	0.000247	0.000538	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—melanoma	0.000244	0.00053	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—melanoma	0.000241	0.000525	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—melanoma	0.000237	0.000515	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—melanoma	0.000236	0.000514	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—melanoma	0.00023	0.000501	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—melanoma	0.000228	0.000496	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—melanoma	0.000224	0.000487	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—melanoma	0.000224	0.000487	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—melanoma	0.000223	0.000485	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—melanoma	0.000222	0.000484	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NFKB1—melanoma	0.000221	0.000481	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—melanoma	0.000207	0.000451	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—melanoma	0.000201	0.000437	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—melanoma	0.000199	0.000433	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRAS—melanoma	0.000198	0.000432	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—melanoma	0.000198	0.000432	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK3—melanoma	0.00019	0.000413	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—melanoma	0.000187	0.000408	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—melanoma	0.000185	0.000402	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—melanoma	0.000183	0.000398	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK1—melanoma	0.000181	0.000393	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—melanoma	0.000181	0.000393	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—melanoma	0.000171	0.000371	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—melanoma	0.000157	0.000341	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—melanoma	0.000156	0.00034	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—melanoma	0.000153	0.000333	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—melanoma	0.000152	0.00033	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—melanoma	0.000145	0.000316	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—melanoma	0.000139	0.000302	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—melanoma	0.000128	0.000279	CbGpPWpGaD
